The company is backed by a talented management team and other staff members who are highly skilled and well aware of the technical know-how
Yet until patients and payers see these results (readout mid-2023 ), will they be able to stomach the cost of GLP-1 drugs
Oral semaglutide (the Wegovy pill) Novo Nordisk launched an oral form of semaglutide for weight loss in the US in January 2026
Among 28,953 NAE reports associated with GLP-1 RAs, 19 distinct NAE signals were identified using reporting odds ratios (RORs), including dizziness, tremor, dysgeusia, lethargy, taste disorder, presyncope, parosmia, allodynia, and hypoglycemic unconsciousness, etc
Patients should reach out to their healthcare provider for specific guidance tailored to their treatment plan